» Articles » PMID: 26197341

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease

Overview
Journal Biomolecules
Publisher MDPI
Date 2015 Jul 22
PMID 26197341
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Abundant evidence has demonstrated that obesity is a state of low-grade chronic inflammation that triggers the release of lipids, aberrant adipokines, pro-inflammatory cytokines, and several chemokines from adipose tissue. This low-grade inflammation underlies the development of insulin resistance and associated metabolic comorbidities such as type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD). During this development, adipose tissue macrophages accumulate through chemokine (C-C motif) receptor 2 and the ligand for this receptor, monocyte chemoattractant protein-1 (MCP-1), is considered to be pivotal for the development of insulin resistance. To date, the chemokine system is known to be comprised of approximately 40 chemokines and 20 chemokine receptors that belong to the seven-transmembrane G protein-coupled receptor family and, as a result, chemokines appear to exhibit a high degree of functional redundancy. Over the past two decades, the physiological and pathological properties of many of these chemokines and their receptors have been elucidated. The present review highlights chemokines and chemokine receptors as key contributing factors that link obesity to insulin resistance, T2DM, and NAFLD.

Citing Articles

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.

Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H Signal Transduct Target Ther. 2024; 9(1):268.

PMID: 39379377 PMC: 11461632. DOI: 10.1038/s41392-024-01954-6.


ADIPOPHILIN PEPTIDE (ADPH 129-137) IS NOT A TARGET ANTIGEN FOR CD8 T-CELLS IN PATIENTS WITH OBESITY.

Asadipour M, Ataollahi M, Shams K, Ali-Hassanzadeh M, Martinuzzi E, Kalantar K Acta Endocrinol (Buchar). 2024; 20(1):21-26.

PMID: 39372296 PMC: 11449246. DOI: 10.4183/aeb.2024.21.


Antioxidant genes in cancer and metabolic diseases: Focusing on Nrf2, Sestrin, and heme oxygenase 1.

Shrestha J, Limbu K, Chhetri R, Paudel K, Hansbro P, Oh Y Int J Biol Sci. 2024; 20(12):4888-4907.

PMID: 39309448 PMC: 11414382. DOI: 10.7150/ijbs.98846.


Semi-supervised meta-learning elucidates understudied molecular interactions.

Wu Y, Xie L, Liu Y, Xie L Commun Biol. 2024; 7(1):1104.

PMID: 39251833 PMC: 11383949. DOI: 10.1038/s42003-024-06797-z.


Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity.

Spehar Uroic A, Filipovic M, Sucur A, Kelava T, Kovacic N, Grcevic D Front Endocrinol (Lausanne). 2024; 15:1335371.

PMID: 39109081 PMC: 11300205. DOI: 10.3389/fendo.2024.1335371.


References
1.
Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. PMC: 296995. DOI: 10.1172/JCI19246. View

2.
Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H . High serum carotenoids are inversely associated with serum gamma-glutamyltransferase in alcohol drinkers within normal liver function. J Epidemiol. 2005; 15(5):180-6. PMC: 7904301. DOI: 10.2188/jea.15.180. View

3.
Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

4.
Day C, James O . Steatohepatitis: a tale of two "hits"?. Gastroenterology. 1998; 114(4):842-5. DOI: 10.1016/s0016-5085(98)70599-2. View

5.
Baggiolini M . Chemokines and leukocyte traffic. Nature. 1998; 392(6676):565-8. DOI: 10.1038/33340. View